Literature DB >> 20947067

Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine.

Celia Goeldner1, Pierre-Eric Lutz, Emmanuel Darcq, Thomas Halter, Daniel Clesse, Abdel-Mouttalib Ouagazzal, Brigitte L Kieffer.   

Abstract

BACKGROUND: Opiate abuse is a chronic relapsing disorder, and maintaining prolonged abstinence remains a major challenge. Protracted abstinence is characterized by lowered mood, and clinical studies show elevated comorbidity between addiction and depressive disorders. At present, their relationship remains unclear and has been little studied in animal models. Here we investigated emotional alterations during protracted abstinence, in mice with a history of chronic morphine exposure.
METHODS: C57BL6J mice were exposed to a chronic intermittent escalating morphine regimen (20-100 mg/kg). Physical dependence (naloxone-precipitated withdrawal), despair-related behaviors (tail suspension test), and social behaviors were examined after 1 or 4 weeks of abstinence. Stress hormones and forebrain bioamine levels were analyzed at the end of morphine regimen and after 4 weeks of abstinence. Finally, we examined the effects of chronic fluoxetine during abstinence on morphine-induced behavioral deficits.
RESULTS: Acute naloxone-induced withdrawal was clearly measurable after 1 week, and became undetectable after 4 weeks. In contrast, social and despair-related behaviors were unchanged after 1 week, but low sociability and despair-like behavior became significant after 4 weeks. Chronic morphine regimen increased both corticosterone levels and forebrain serotonin turnover, but only serotonergic activity in the dorsal raphe remained impaired after 4 weeks. Remarkably, chronic fluoxetine prevented depressive-like behavioral deficits in 4-week abstinent mice.
CONCLUSIONS: During protracted abstinence, the immediate consequences of morphine exposure attenuate, whereas fluoxetine-sensitive emotional alterations strengthen with time. Our study establishes a direct link between morphine abstinence and depressive-like symptoms and strongly suggests that serotonin dysfunction represents a main mechanism contributing to mood disorders in opiate abstinence. Copyright Â
© 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947067      PMCID: PMC3014999          DOI: 10.1016/j.biopsych.2010.08.021

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  74 in total

1.  Maintenance of conditioned place preferences and aversion in C57BL6 mice: effects of repeated and drug state testing.

Authors:  Kazuto Sakoori; Niall P Murphy
Journal:  Behav Brain Res       Date:  2004-12-29       Impact factor: 3.332

2.  Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal.

Authors:  G C Harris; G Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2001-01       Impact factor: 7.853

3.  Persistence of "relapse-tendencies" of rats previously made physically dependent on morphine.

Authors:  A Wikler; F T Pescor
Journal:  Psychopharmacologia       Date:  1970

4.  Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.

Authors:  E V Nunes; F M Quitkin; S J Donovan; D Deliyannides; K Ocepek-Welikson; T Koenig; R Brady; P J McGrath; G Woody
Journal:  Arch Gen Psychiatry       Date:  1998-02

5.  Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.

Authors:  Maree Teesson; Alys Havard; Sandra Fairbairn; Joanne Ross; Michael Lynskey; Shane Darke
Journal:  Drug Alcohol Depend       Date:  2005-06-01       Impact factor: 4.492

Review 6.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

7.  Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats.

Authors:  Hajnalka Kompagne; György Bárdos; Gábor Szénási; István Gacsályi; László G Hársing; György Lévay
Journal:  Behav Brain Res       Date:  2008-06-11       Impact factor: 3.332

8.  Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone.

Authors:  V A Molina; C J Heyser; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

Review 9.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

10.  Morphine withdrawal decreases responding reinforced by sucrose self-administration in progressive ratio.

Authors:  Dengke Zhang; Xuhui Zhou; Xuyi Wang; Xiaojun Xiang; Hongxian Chen; Wei Hao
Journal:  Addict Biol       Date:  2007-06       Impact factor: 4.280

View more
  57 in total

1.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.

Authors:  Brennon R Luster; Elizabeth S Cogan; Karl T Schmidt; Dipanwita Pati; Melanie M Pina; Kedar Dange; Zoé A McElligott
Journal:  Addict Biol       Date:  2019-04-09       Impact factor: 4.280

3.  Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in mice.

Authors:  C Del Boca; P E Lutz; J Le Merrer; P Koebel; B L Kieffer
Journal:  Neuroscience       Date:  2012-05-18       Impact factor: 3.590

Review 4.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

5.  The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.

Authors:  Panos Zanos; Polymnia Georgiou; Sherie R Wright; Susanna M Hourani; Ian Kitchen; Raphaëlle Winsky-Sommerer; Alexis Bailey
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

6.  Longitudinal changes of dopamine transporters in heroin users during abstinence.

Authors:  Shasha Xu; Ying Liu; Yu Li; Yangping Deng; Yiyun Huang; Jie Yuan; Rongbin Lv; Yuankai Wang; Guangming Zhang; Zhirui Guo; Mei Han; Xingdang Liu; Daxu Fu
Journal:  Psychopharmacology (Berl)       Date:  2015-06-23       Impact factor: 4.530

7.  Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.

Authors:  Aura C Meirsman; Julie Le Merrer; Lucie P Pellissier; Jorge Diaz; Daniel Clesse; Brigitte L Kieffer; Jérôme A J Becker
Journal:  Biol Psychiatry       Date:  2015-06-06       Impact factor: 13.382

8.  Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains.

Authors:  G Ayranci; K Befort; L Lalanne; B L Kieffer; P-E Lutz
Journal:  Psychopharmacology (Berl)       Date:  2014-12-09       Impact factor: 4.530

Review 9.  The multiple facets of opioid receptor function: implications for addiction.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Curr Opin Neurobiol       Date:  2013-02-28       Impact factor: 6.627

10.  Divergent behavioral responses in protracted opioid withdrawal in male and female C57BL/6J mice.

Authors:  Isabel M Bravo; Brennon R Luster; Meghan E Flanigan; Patric J Perez; Elizabeth S Cogan; Karl T Schmidt; Zoe A McElligott
Journal:  Eur J Neurosci       Date:  2019-10-06       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.